Global Allergy Diagnostics Market Report 2022: Market To

Dublin, June 07, 2022 (GLOBE NEWSWIRE) — The ‘Allergy Diagnostics – Global Market Trajectory & Analytics’ report has been added to from offer.

Global allergy diagnostics market to reach US$5.7 billion by 2026

The global allergy diagnostics market, estimated to be worth US$3.8 billion in 2022, is expected to reach a revised size of US$5.7 billion by 2026, growing at a CAGR of 9.3% over the analysis period.

The global allergy diagnostics market, after slowing for some time due to the Covid-19 effect, is recovering and growing, driven by the increase in allergy cases resulting from exposure to pollution and increased consumption of processed foods as well as dairy and confectionery products. .

The increasing prevalence of allergies and the associated health implications justify an urgent need for effective diagnosis and treatment. The rapid increase in the incidence of allergies coupled with changing dietary habits plays a pivotal role in strengthening the allergy diagnostics market. The growth of the market is also augmented by the increase in the level of environmental pollution and the resultant increase in the number of allergy sufferers.

Changing lifestyles and dietary habits, coupled with rapid urbanization and increasing levels of outdoor and indoor pollution, are likely to increase the incidence of allergic conditions. Market growth is also estimated to be propelled by strong demand for in vitro diagnostic blood tests.

Test Kits, one of the segments analyzed in the report, is expected to grow at a CAGR of 10% to reach US$3.3 billion by the end of the analysis period.

After a thorough analysis of the business implications of the pandemic and the induced economic crisis, the growth of the Instruments segment is readjusted to a revised CAGR of 9.2% for the next 7-year period. This segment currently accounts for a 28.2% share of the global allergy diagnostics market.

The test kits are expected to see strong demand fueled by key factors such as growing preference for test kits by physicians in allergy testing, high prevalence of allergic diseases and increasing testing volumes. Wide product availability and the need for repeat purchases in allergy testing are also expected to drive high consumption of test kits in the coming years.

Despite the high cost of instruments, the segment is expected to hold a large share owing to the long lifespan of instruments and limited need for frequent installations. The purchase of used instruments by smaller healthcare organizations also increases the instrument market share.

The US market is estimated at $1.3 billion in 2022, while China is expected to reach $622.5 million by 2026

The allergy diagnostics market in the United States is estimated to be worth US$1.3 billion in 2022. The country currently accounts for a 34.21% share of the global market. China, the second largest economy in the world, is expected to reach an estimated market size of US$622.5 million in 2026 growing at a CAGR of 13.8% over the analysis period.

Other noteworthy geographic markets include Japan and Canada, each forecasting growth of 7.1% and 8.9% respectively over the analysis period. In Europe, Germany is expected to grow at a CAGR of approximately 8.8%, while the rest of the European market (as defined in the study) will reach US$189.6 million by the end of the year. analysis period.

Although developed regions are major revenue contributors, developing regions have emerged as hotspots for the future growth of the allergy diagnostics market. Factors such as increased public and private sector investment in health, increased incidence of allergies, improved access to health care and increased levels of awareness promote market growth in developing regions.

Services segment to reach $1.1 billion by 2026

In the global services segment, the United States, Canada, Japan, China and Europe will drive the estimated CAGR of 7.5% for this segment. These regional markets representing a combined market size of US$544.4 million will reach a projected size of US$872.6 million by the end of the analysis period.

China will remain among the fastest growing markets in this group of regional markets. Led by countries such as Australia, India, and South Korea, the Asia-Pacific market is expected to reach US$124.1 million by 2026, while Latin America will expand to a CAGR of 9.6% over the analysis period.

Main topics covered:




  • Allergens: a prelude
  • Key Allergy Statistics
  • Allergy: symptoms and causes
  • Allergy diagnosis: an introduction
  • Food allergen analysis
  • Impact of Covid-19 and a looming global recession
  • The allergy diagnostics market under the lens of Covid
  • Telemedicine gains prominence amid pandemic
  • Global Allergy Diagnostics Market Expected to Grow Rapidly
  • With allergies on the rise for whatever reason, be it our Neanderthal genes, the hygiene hypothesis, or the vitamin D hypothesis, the need for effective diagnostics has never been greater.
  • Assay kits dominate the allergy diagnostic market
  • The inhaled allergen segment will see the fastest growth
  • US Dominates Allergy Diagnostics Market, China to See Fastest Growth
  • Growing demand for in vitro diagnostic tests for allergy diagnosis
    Recent market activity
  • Competitive Market Presence – Strong/Active/Niche/Trivial for 67 players globally in 2022 (E)

2. FOCUS ON CERTAIN PLAYERS (Total 100 Featured)

  • Alk Abello A/S
  • Allergy Therapeutics PLC
  • ALCO
  • Angsana Molecular & Diagnostics Laboratory Pte. ltd.
  • Astra Biotech GmbH
  • biomerieux SA
  • Demeditec Diagnostics GmbH
  • EUROIMMUN Medizinische Labordiagnostika AG
  • GA Generic Assays GmbH
  • INDOOR Biotechnologies, Inc.
  • Lincoln Diagnostics, Inc.
  • Omega Diagnostics Group Plc
  • R-Biopharm Ag
  • Roxall Medizin GmbH
  • Siemens Healthineers
  • Stallergenes Greer
  • Tecan Trading SA
  • Theradiag
  • Thermo Fisher Scientific Inc.


  • Development of effective allergy diagnostic products reduces healthcare costs
  • Laboratories embrace automation and advanced allergy testing for fast turnaround times
  • Food Allergies – A Major and Growing Concern
  • Select digital technologies to help manage food allergies
  • Food allergies create opportunities for food allergy testing
  • ELISA gains lead as preferred food testing method
  • The need to offer quality services at affordable costs is driving laboratories to consider reagent rental contracts
  • In vitro IgE molecular diagnostics to transform the allergy testing market
  • Macro Array Diagnostics Unveils Allergy Explorer for Allergy Diagnosis
  • Rise in alcohol and drug abuse increases demand for allergy diagnostics
  • Rise in Allergy Cases Drive Development of Advanced Allergy Diagnostic Solutions
  • Focus on simple and protein allergens
  • IgE Antibody Tests
  • Microchip allergy diagnostic reagents
  • Allergy diagnosis shifts from laboratory-based POC testing to decentralized POC testing
  • Patch test for healthy growth
  • SmartPractice Obtains FDA Approval for TRUE Test(R) Pediatric Patch Test
  • Allergy diagnostic service providers focus on vertical integration
  • Allergic diagnostic challenges in patients
  • Enhanced Access to Allergy Diagnosis Medical Insurance and Instrument Allowances in the United States Expanding Market Insights
  • Technological Advances – Mobile Health Tools for Allergy Patients
  • Technological Advances – Nanotechnology for Allergy Diagnosis
  • Application of nanostructures for the in vitro diagnosis of allergy
  • Application of nanostructures in sIgE-drug detection
  • Application of nanostructures for the detection of allergens-sIgE
  • Select recent launches in allergy diagnostics market to support market expansion
  • EUROIMMUM develops the EUROLINE DPA-Dx Pollen Southern Europe 1 test for pollen allergies
  • Hycor Biomedical Obtains FDA Clearance for NOVEOS Allergy Testing System
  • ASI Introduces IVT Allergy(R) 3 Screen Panel for Allergy Skin Testing
  • CLA-1(TM) Luminometer In Vitro Allergy Testing Platform for Accurate and Reliable Results
  • Growth engines
  • Increase in prevalence and incidence of allergic disorders to drive demand for allergy diagnostics
  • Environmental changes and pollution aggravate the incidence of allergic reactions, leading to an increased need for allergic diagnostics
  • Main environmental factors linked to allergic diseases
  • Rising number of food allergy cases fuels demand for allergy test kits
  • Factors responsible for the growing prevalence of food allergies
  • Booming Aging Population and Longer Life Expectancy to Drive Allergy Diagnostics Market
  • Market constraints
  • Insufficient Food Allergy Knowledge Inhibits Allergy Diagnostics Market Growth
  • Expensive Nature of Allergy Diagnostic Approaches Limits Market Growth
  • New Regulations and Legislation Regarding Diagnostic Allergen Extracts




For more information about this report visit

More Stories
Builders FirstSource, Inc. (NYSE: BLDR) Receives Average “Buy” Recommendation From Brokerages